Yendewa, G. A., Griffiss, J. M., Jacobs, M. R., Winkle, P., Gray, W. A., Proskin, H. M., . . . Salata, R. A. (2019). A two-part phase I study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonization of Staphylococcus aureus: A previously investigated 0.5 mg/g viscosified gel formulation versus a modified formulation. J Glob Antimicrob Resist.

Yendewa, George A., J. McLeod Griffiss, Michael R. Jacobs, Peter Winkle, Wesley A. Gray, Howard M. Proskin, Mary Ann O’Riordan, Scott A. Fulton, and Robert A. Salata. "A Two-part Phase I Study to Establish and Compare the Safety and Local Tolerability of Two Nasal Formulations of XF-73 for Decolonization of Staphylococcus Aureus: A Previously Investigated 0.5 Mg/g Viscosified Gel Formulation Versus a Modified Formulation." J Glob Antimicrob Resist 2019.

Yendewa, George A., et al. "A Two-part Phase I Study to Establish and Compare the Safety and Local Tolerability of Two Nasal Formulations of XF-73 for Decolonization of Staphylococcus Aureus: A Previously Investigated 0.5 Mg/g Viscosified Gel Formulation Versus a Modified Formulation." J Glob Antimicrob Resist 2019.